{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:52:15Z","timestamp":1790376735015,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>SLC6A14-mediated l-arginine transport has been shown to augment the residual anion channel activity of the major mutant, F508del-CFTR, in the murine gastrointestinal tract. It is not yet known if this transporter augments residual and pharmacological corrected F508del-CFTR in primary airway epithelia. We sought to determine the role of l-arginine uptake via SLC6A14 in modifying F508del-CFTR channel activity in airway cells from patients with cystic fibrosis (CF). Human bronchial epithelial (HBE) cells from lung explants of patients without CF (HBE) and those with CF (CF-HBE) were used for H3-flux, airway surface liquid, and Ussing chamber studies. We used \u03b1-methyltryptophan as a specific inhibitor for SLC6A14. CFBE41o\u2212, a commonly used CF airway cell line, was employed for studying the mechanism of the functional interaction between SLC6A14 and F508del-CFTR. SLC6A14 is functionally expressed in CF-HBE cells. l-arginine uptake via SLC6A14 augmented F508del-CFTR function at baseline and after treatment with lumacaftor. SLC6A14-mediated l-arginine uptake also increased the airway surface liquid in CF-HBE cells. Using CFBE41o cells, we showed that the positive SLC6A14 effect was mainly dependent on the nitric oxide (NO) synthase activity, nitrogen oxides, including NO, and phosphorylation by protein kinase G. These finding were confirmed in CF-HBE, as inducible NO synthase inhibition abrogated the functional interaction between SLC6A14 and pharmacological corrected F508del-CFTR. In summary, SLC6A14-mediated l-arginine transport augments residual F508del-CFTR channel function via a noncanonical, NO pathway. This effect is enhanced with increasing pharmacological rescue of F508del-CFTR to the membrane. The current study demonstrates how endogenous pathways can be used for the development of companion therapy in CF.<\/jats:p>","DOI":"10.1165\/rcmb.2019-0094oc","type":"journal-article","created":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T18:06:21Z","timestamp":1560362781000},"page":"755-764","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":17,"title":["Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis"],"prefix":"10.1093","volume":"61","author":[{"given":"Saumel","family":"Ahmadi","sequence":"first","affiliation":[{"name":"Department of Physiology"},{"name":"Programme in Molecular Medicine"},{"name":"Programme in Genetics and Genome Biology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Physiology"},{"name":"Programme in Molecular Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9641-9284","authenticated-orcid":false,"given":"Mingyuan","family":"Li","sequence":"additional","affiliation":[{"name":"Programme in Translational Medicine, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Ip","sequence":"additional","affiliation":[{"name":"Programme in Translational Medicine, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Lloyd-Kuzik","sequence":"additional","affiliation":[{"name":"Department of Physiology"},{"name":"Programme in Translational Medicine, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Di Paola","sequence":"additional","affiliation":[{"name":"Department of Physiology"},{"name":"Programme in Molecular Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny","family":"Xia","sequence":"additional","affiliation":[{"name":"Department of Physiology"},{"name":"Programme in Molecular Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandria","family":"Lew","sequence":"additional","affiliation":[{"name":"Programme in Molecular Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Bozoky","sequence":"additional","affiliation":[{"name":"Programme in Molecular Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Forman-Kay","sequence":"additional","affiliation":[{"name":"Programme in Molecular Medicine"},{"name":"Department of Biochemistry, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Bear","sequence":"additional","affiliation":[{"name":"Department of Physiology"},{"name":"Programme in Molecular Medicine"},{"name":"Department of Biochemistry, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6786-4354","authenticated-orcid":false,"given":"Tanja","family":"Gonska","sequence":"additional","affiliation":[{"name":"Programme in Translational Medicine, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada"},{"name":"Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,12,1]]},"reference":[{"key":"2026021100393648400_bib1","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"key":"2026021100393648400_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/(SICI)1099-0496(199612)22:6<387::AID-PPUL7>3.0.CO;2-G","article-title":"Genotype-phenotype correlations in cystic fibrosis","volume":"22","author":"Kerem","year":"1996","journal-title":"Pediatr Pulmonol"},{"key":"2026021100393648400_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nsmb882","article-title":"The deltaF508 cystic fibrosis mutation impairs domain\u2013domain interactions and arrests post-translational folding of CFTR","volume":"12","author":"Du","year":"2005","journal-title":"Nat Struct Mol Biol"},{"key":"2026021100393648400_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.molmed.2007.05.001","article-title":"Cystic fibrosis: a disease of vulnerability to airway surface dehydration","volume":"13","author":"Boucher","year":"2007","journal-title":"Trends Mol Med"},{"key":"2026021100393648400_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jcf.2005.05.005","article-title":"Infection and inflammation in cystic fibrosis: a short review","volume":"4","author":"Heijerman","year":"2005","journal-title":"J Cyst Fibros"},{"key":"2026021100393648400_bib6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N Engl J Med"},{"key":"2026021100393648400_bib7","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1080\/14656566.2018.1505864","article-title":"New anti-pseudomonal agents for cystic fibrosis- still needed in the era of small molecule CFTR modulators?","volume":"19","author":"Davies","year":"2018","journal-title":"Expert Opin Pharmacother"},{"key":"2026021100393648400_bib8","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ng.2221","article-title":"Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis","volume":"44","author":"Sun","year":"2012","journal-title":"Nat Genet"},{"key":"2026021100393648400_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00439-013-1363-7","article-title":"Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities","volume":"133","author":"Li","year":"2013","journal-title":"Hum Genet"},{"key":"2026021100393648400_bib10","first-page":"L917","article-title":"An electrogenic amino acid transporter in the apical membrane of cultured human bronchial epithelial cells","volume":"275","author":"Galietta","year":"1998","journal-title":"Am J Physiol"},{"key":"2026021100393648400_bib11","doi-asserted-by":"crossref","first-page":"L39","DOI":"10.1152\/ajplung.00164.2002","article-title":"Expression of the amino acid transporter ATB 0+ in lung: possible role in luminal protein removal","volume":"284","author":"Sloan","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026021100393648400_bib12","doi-asserted-by":"crossref","first-page":"23740","DOI":"10.1074\/jbc.274.34.23740","article-title":"Cloning and functional expression of a human Na(+) and Cl(\u2212)-dependent neutral and cationic amino acid transporter B(0+)","volume":"274","author":"Sloan","year":"1999","journal-title":"J Biol Chem"},{"key":"2026021100393648400_bib13","doi-asserted-by":"crossref","first-page":"31830","DOI":"10.1074\/jbc.M111.229518","article-title":"SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor\u2013positive breast cancer","volume":"286","author":"Karunakaran","year":"2011","journal-title":"J Biol Chem"},{"key":"2026021100393648400_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00424-013-1410-1","article-title":"The SLC6 transporters: perspectives on structure, functions, regulation, and models for transporter dysfunction","volume":"466","author":"Rudnick","year":"2014","journal-title":"Pflugers Arch"},{"key":"2026021100393648400_bib15","doi-asserted-by":"crossref","first-page":"e37963","DOI":"10.7554\/eLife.37963","article-title":"SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion","volume":"7","author":"Ahmadi","year":"2018","journal-title":"eLife"},{"key":"2026021100393648400_bib16","doi-asserted-by":"crossref","first-page":"10260","DOI":"10.1073\/pnas.1106695108","article-title":"Human cystic fibrosis airway epithelia have reduced Cl\u2212 conductance but not increased Na+ conductance","volume":"108","author":"Itani","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026021100393648400_bib17","doi-asserted-by":"crossref","first-page":"15034","DOI":"10.1038\/mtm.2015.34","article-title":"Testing gene therapy vectors in human primary nasal epithelial cultures","volume":"2","author":"Cao","year":"2015","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2026021100393648400_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-61779-120-8_5","article-title":"Methods for ASL measurements and mucus transport rates in cell cultures","volume":"742","author":"Worthington","year":"2011","journal-title":"Methods Mol Biol"},{"key":"2026021100393648400_bib19","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1177\/1087057115605834","article-title":"Facilitating structure-function studies of CFTR modulator sites with efficiencies in mutagenesis and functional screening","volume":"20","author":"Molinski","year":"2015","journal-title":"J Biomol Screen"},{"key":"2026021100393648400_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41525-017-0015-6","article-title":"Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia","volume":"2","author":"Ahmadi","year":"2017","journal-title":"NPJ Genom Med"},{"key":"2026021100393648400_bib21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jcf.2014.09.012","article-title":"Aggregates of mutant CFTR fragments in airway epithelial cells of CF lungs: new pathologic observations","volume":"14","author":"Du","year":"2015","journal-title":"J Cyst Fibros"},{"key":"2026021100393648400_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1042\/BJ20080622","article-title":"Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapy","volume":"414","author":"Karunakaran","year":"2008","journal-title":"Biochem J"},{"key":"2026021100393648400_bib23","doi-asserted-by":"crossref","first-page":"pii: e02073-17","DOI":"10.1128\/mBio.02073-17","article-title":"SLC6A14 is a genetic modifier of cystic fibrosis that regulates Pseudomonas aeruginosa attachment to human bronchial epithelial cells","volume":"8","author":"Di Paola","year":"2017","journal-title":"MBio"},{"key":"2026021100393648400_bib24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1085\/jgp.200509468","article-title":"Soluble mediators, not cilia, determine airway surface liquid volume in normal and cystic fibrosis superficial airway epithelia","volume":"127","author":"Tarran","year":"2006","journal-title":"J Gen Physiol"},{"key":"2026021100393648400_bib25","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.15252\/emmm.201607137","article-title":"Orkambi\u00ae and amplifier co-therapy improves function from a rare CFTR mutation in gene-edited cells and patient tissue","volume":"9","author":"Molinski","year":"2017","journal-title":"EMBO Mol Med"},{"key":"2026021100393648400_bib26","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1074\/jbc.272.8.4959","article-title":"1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo","volume":"272","author":"Garvey","year":"1997","journal-title":"J Biol Chem"},{"key":"2026021100393648400_bib27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00006676-199908000-00009","article-title":"Nitric oxide inhibits whole-cell current in cystic fibrosis pancreatic epithelial cells","volume":"19","author":"Thethi","year":"1999","journal-title":"Pancreas"},{"key":"2026021100393648400_bib28","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-9258(17)42310-6","article-title":"Activation of the cystic fibrosis transmembrane conductance regulator by cGMP in the human colonic cancer cell line, Caco-2","volume":"269","author":"Tien","year":"1994","journal-title":"J Biol Chem"},{"key":"2026021100393648400_bib29","doi-asserted-by":"crossref","first-page":"12742","DOI":"10.1016\/S0021-9258(18)42339-3","article-title":"Phosphorylation of the cystic fibrosis transmembrane conductance regulator","volume":"267","author":"Picciotto","year":"1992","journal-title":"J Biol Chem"},{"key":"2026021100393648400_bib30","doi-asserted-by":"crossref","first-page":"28463","DOI":"10.1074\/jbc.271.45.28463","article-title":"ATPase activity of the cystic fibrosis transmembrane conductance regulator","volume":"271","author":"Li","year":"1996","journal-title":"J Biol Chem"},{"key":"2026021100393648400_bib31","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.bbrc.2013.12.130","article-title":"S-nitrosothiols increases cystic fibrosis transmembrane regulator expression and maturation in the cell surface","volume":"443","author":"Zaman","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"2026021100393648400_bib32","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1124\/mol.106.023242","article-title":"S-nitrosylating agents: a novel class of compounds that increase cystic fibrosis transmembrane conductance regulator expression and maturation in epithelial cells","volume":"70","author":"Zaman","year":"2006","journal-title":"Mol Pharmacol"},{"key":"2026021100393648400_bib33","doi-asserted-by":"crossref","first-page":"L450","DOI":"10.1152\/ajplung.2001.281.2.L450","article-title":"Regulation of anion secretion by nitric oxide in human airway epithelial cells","volume":"281","author":"Duszyk","year":"2001","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026021100393648400_bib34","doi-asserted-by":"crossref","first-page":"L712","DOI":"10.1152\/ajplung.00314.2006","article-title":"Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis","volume":"293","author":"Poschet","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2026021100393648400_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1208\/s12248-017-0164-7","article-title":"The Na+\/Cl\u2212-coupled, broad-specific, amino acid transporter SLC6A14 (ATB0,+): emerging roles in multiple diseases and therapeutic potential for treatment and diagnosis","volume":"20","author":"Sikder","year":"2017","journal-title":"AAPS J"},{"key":"2026021100393648400_bib36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/44.5.8627003","article-title":"Localization of endothelial NOS at the basal microtubule membrane in ciliated epithelium of rat lung","volume":"44","author":"Xue","year":"1996","journal-title":"J Histochem Cytochem"},{"key":"2026021100393648400_bib37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1378\/chest.09-2090","article-title":"Exhaled nitric oxide in pulmonary diseases: a comprehensive review","volume":"138","author":"Barnes","year":"2010","journal-title":"Chest"},{"key":"2026021100393648400_bib38","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/(SICI)1099-0496(199912)28:6<442::AID-PPUL10>3.0.CO;2-4","article-title":"Cystic fibrosis lung disease: the role of nitric oxide","volume":"28","author":"Grasemann","year":"1999","journal-title":"Pediatr Pulmonol"},{"key":"2026021100393648400_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1465-9921-7-87","article-title":"Decreased systemic bioavailability of L-arginine in patients with cystic fibrosis","volume":"7","author":"Grasemann","year":"2006","journal-title":"Respir Res"},{"key":"2026021100393648400_bib40","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1164\/rccm.200502-253OC","article-title":"Increased arginase activity in cystic fibrosis airways","volume":"172","author":"Grasemann","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021100393648400_bib41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/(SICI)1099-0496(199709)24:3<173::AID-PPUL2>3.0.CO;2-O","article-title":"Decreased concentration of exhaled nitric oxide (NO) in patients with cystic fibrosis","volume":"24","author":"Grasemann","year":"1997","journal-title":"Pediatr Pulmonol"},{"key":"2026021100393648400_bib42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ppul.21137","article-title":"Low levels of exhaled nitric oxide are associated with impaired lung function in cystic fibrosis","volume":"45","author":"Keen","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"2026021100393648400_bib43","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1128\/IAI.71.5.2341-2349.2003","article-title":"Effects of nitric oxide on Pseudomonas aeruginosa infection of epithelial cells from a human respiratory cell line derived from a patient with cystic fibrosis","volume":"71","author":"Darling","year":"2003","journal-title":"Infect Immun"},{"key":"2026021100393648400_bib44","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1128\/IAI.01807-06","article-title":"In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients","volume":"75","author":"Son","year":"2007","journal-title":"Infect Immun"},{"key":"2026021100393648400_bib45","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/thorax.55.9.795","article-title":"Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease","volume":"55","author":"Thomas","year":"2000","journal-title":"Thorax"},{"key":"2026021100393648400_bib46","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jcf.2012.12.008","article-title":"A randomized controlled trial of inhaled L-arginine in patients with cystic fibrosis","volume":"12","author":"Grasemann","year":"2013","journal-title":"J Cyst Fibros"},{"key":"2026021100393648400_bib47","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1113\/jphysiol.2013.261909","article-title":"The secret life of CFTR as a calcium-activated chloride channel","volume":"591","author":"Billet","year":"2013","journal-title":"J Physiol"},{"key":"2026021100393648400_bib48","doi-asserted-by":"crossref","first-page":"E2086","DOI":"10.1073\/pnas.1613546114","article-title":"Synergy of cAMP and calcium signaling pathways in CFTR regulation","volume":"114","author":"Bozoky","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026021100393648400_bib49","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ceca.2014.04.003","article-title":"Electrical coupling between the human serotonin transporter and voltage-gated Ca(2+) channels","volume":"56","author":"Ruchala","year":"2014","journal-title":"Cell Calcium"},{"key":"2026021100393648400_bib50","doi-asserted-by":"crossref","first-page":"L912","DOI":"10.1152\/ajplung.00178.2016","article-title":"The CFTR trafficking mutation F508del inhibits the constitutive activity of SLC26A9","volume":"312","author":"Bertrand","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/61\/6\/755\/66762382\/ajrcmb_61_6_755.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/61\/6\/755\/66762382\/ajrcmb_61_6_755.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T05:39:50Z","timestamp":1770788390000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/61\/6\/755\/8461454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,1]]},"references-count":50,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,12,1]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2019-0094oc","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,12]]},"published":{"date-parts":[[2019,12,1]]},"assertion":[{"value":"2019-03-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}